Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 82551-82600 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05403658
Attrition in Pediatric Obesity Management
NAActive, not recruiting
108 participants
Started: Oct 14, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06379282
Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic Leukaemia
NARecruiting
132 participants
Started: Oct 14, 2022 · Completed: Aug 1, 2026
5 conditions2 sponsors1 location
NCT06591013
Efficacy and Mechanism of Fecal Microbiota Transplantation of the Bai Nationality in the Treatment of IBD
NAEnrolling by invitation
60 participants
Started: Oct 14, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05565378
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
PHASE2Active, not recruiting
351 participants
Started: Oct 14, 2022 · Completed: Feb 26, 2027
1 condition2 sponsors101 locations
NCT04296071
Neutrophil Phenotypic Profiling and Acute Lung Injury in Patients After Cardiopulmonary Bypass (CPB)
N/ARecruiting
56 participants
Started: Oct 14, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05511701
Preventing Ischemic Heart Disease With mHealth (Mobile Health), Electronic Decision Support and Community Health Workers
NARecruiting
954 participants
Started: Oct 14, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT04953364
Self-Management for Amputee Rehabilitation Using Technology.
NARecruiting
82 participants
Started: Oct 14, 2022 · Completed: Feb 1, 2026
5 conditions2 sponsors1 location
NCT05725187
Prospective Validation Study of AI-based Prediction Algorithm for the Prediction of Paroxysmal Atrial Fibrillation
N/AEnrolling by invitation
600 participants
Started: Oct 14, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors11 locations
NCT05384132
Novel Dental Gel as an Adjunct to Scaling and Root Planing
NARecruiting
76 participants
Started: Oct 14, 2022 · Completed: Oct 31, 2026
5 conditions1 sponsor1 location
NCT05686434
Osimertinib Therapy After Resection in High-risk Stage I EGFRm NSCLC (OSTAR)
PHASE2Recruiting
65 participants
Started: Oct 14, 2022 · Completed: Oct 14, 2029
1 condition1 sponsor1 location
NCT05357794
Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides
PHASE2Recruiting
30 participants
Started: Oct 13, 2022 · Completed: Jan 30, 2026
1 condition2 sponsors1 location
NCT05587114
Comparision of Various Biomarkers Between Peripheral and Pulmonary Blood
N/ARecruiting
150 participants
Started: Oct 13, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05544760
CatchU: A Quantitative Multisensory Falls-Assessment Study
NAActive, not recruiting
84 participants
Started: Oct 13, 2022 · Completed: Jun 27, 2026
4 conditions3 sponsors1 location
NCT06231953
A Prospective, Multi-center Clinical Study to Establish Multi-Cancer Early Detection Platform Through the Analysis of Whole Genome Sequencing of Circulating DNA in Cancer Patients and Healthy Volunteers
N/ARecruiting
4,000 participants
Started: Oct 13, 2022 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05438121
STabilization of Atheroma by Lipid-reducing Effect of Drug-Coated Balloon (STABLE-DCB)
N/ARecruiting
65 participants
Started: Oct 13, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT05565482
Work Chat: An Interactive Virtual Workday
NAEnrolling by invitation
300 participants
Started: Oct 13, 2022 · Completed: Feb 1, 2026
2 conditions6 sponsors1 location
NCT05403944
Strength or Power Training for Patellofemoral Pain
NAActive, not recruiting
88 participants
Started: Oct 13, 2022 · Completed: Sep 30, 2027
1 condition3 sponsors3 locations
NCT05586100
Neoadjuvant and Adjuvant Toripalimab and Cetuximab in Patients With Recurrent, Resectable Squamous Cell Carcinoma of Head and Neck: a Prospective, Single-arm,Phase II Study
PHASE2Active, not recruiting
52 participants
Started: Oct 13, 2022 · Completed: Apr 28, 2026
1 condition1 sponsor1 location
NCT05761366
Application of 18F-PSMA PET / CT Imaging in Prostate Specific Membrane Antigen Positive Tumor
PHASE2Recruiting
400 participants
Started: Oct 13, 2022 · Completed: Oct 13, 2025
1 condition1 sponsor1 location
NCT05185947
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer
PHASE2Active, not recruiting
19 participants
Started: Oct 13, 2022 · Completed: Apr 4, 2025
10 conditions1 sponsor1 location
NCT05479422
Optilume Registry for Treatment of Stricture of the Anterior Urethra
N/AActive, not recruiting
150 participants
Started: Oct 13, 2022 · Completed: Aug 15, 2029
1 condition2 sponsors13 locations
NCT05573932
Gamified Rehab vs Take-home Packet Rehab for Non-specific Low Back Pain
NAActive, not recruiting
40 participants
Started: Oct 13, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05499182
Latino Teen Depression Treatment Study
N/ARecruiting
35 participants
Started: Oct 13, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05776459
Efficacy and Safety of AC102 Compared to Steroids in Adults with Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
PHASE2Recruiting
210 participants
Started: Oct 13, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor40 locations
NCT05275881
Impact of Virtual Reality in Hematology and Oncology During Invasive Procedures in Children, Adolescents and Young Adults, from 7 to Less Than 25 Years Old
NARecruiting
60 participants
Started: Oct 13, 2022 · Completed: Dec 13, 2026
5 conditions1 sponsor1 location
NCT05046717
Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura
N/ARecruiting
500 participants
Started: Oct 13, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor6 locations
NCT06814626
Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients with Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome
PHASE3Recruiting
72 participants
Started: Oct 13, 2022 · Completed: Dec 31, 2025
3 conditions1 sponsor2 locations
NCT04642157
Online Referral and Intervention to Prevent Adolescent and Young Adult Suicide
NARecruiting
396 participants
Started: Oct 13, 2022 · Completed: Jul 13, 2026
1 condition2 sponsors1 location
NCT05201352
Evaluation of Efficacy of Trifluridine/Tipiracil Plus an Anti-IL-1α True Human Antibody Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine
PHASE1/PHASE2Active, not recruiting
160 participants
Started: Oct 13, 2022 · Completed: Oct 13, 2026
1 condition1 sponsor14 locations
NCT05594498
A Study of StrataXRT in the Prevention of Radiation Dermatitis in Breast Cancer Patients
NAActive, not recruiting
45 participants
Started: Oct 13, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05393232
Groceries for Black Residents of Boston to Stop Hypertension Among Adults With Treated Hypertension
NAActive, not recruiting
150 participants
Started: Oct 13, 2022 · Completed: Oct 31, 2025
1 condition2 sponsors1 location
NCT05396638
Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder
NARecruiting
30 participants
Started: Oct 13, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05663840
Effects of Exercise on Dystonia Pathophysiology
NARecruiting
56 participants
Started: Oct 13, 2022 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05575908
Expert@Work - Effectiveness of a Digital Expert Team on Return to Work
NAActive, not recruiting
170 participants
Started: Oct 13, 2022 · Completed: Dec 31, 2026
2 conditions2 sponsors4 locations
NCT06211595
Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy
NAActive, not recruiting
10 participants
Started: Oct 13, 2022 · Completed: Nov 30, 2024
1 condition1 sponsor1 location
NCT05532865
Prospective Cohort of Patients With Systemic Sclerosis at Brest University Hospital With Biobanking
N/ARecruiting
100 participants
Started: Oct 13, 2022 · Completed: Oct 13, 2032
1 condition1 sponsor1 location
NCT05271916
First-line Treatment With Dacomitinib Plus Anlotinib for Patients With Advanced NSCLC With EGFR 21L858R Mutations
PHASE1/PHASE2Recruiting
140 participants
Started: Oct 13, 2022 · Completed: May 1, 2027
1 condition1 sponsor1 location
NCT05616312
Patient Recall After Orthopedic Trauma
NARecruiting
216 participants
Started: Oct 13, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05650359
Study of the Use of Orthopulse Photobiomodulation
NARecruiting
42 participants
Started: Oct 13, 2022 · Completed: May 15, 2028
1 condition2 sponsors1 location
NCT05490927
Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults
NARecruiting
90 participants
Started: Oct 13, 2022 · Completed: Jul 31, 2025
2 conditions1 sponsor1 location
NCT05455320
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
PHASE3Active, not recruiting
864 participants
Started: Oct 13, 2022 · Completed: Jun 30, 2029
1 condition1 sponsor216 locations
NCT05385315
Towards the Validation of a New Blood Biomarker for the Early Diagnosis of Parkinson's Disease
N/ARecruiting
70 participants
Started: Oct 13, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT04414514
Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
PHASE2Recruiting
24 participants
Started: Oct 13, 2022 · Completed: Jan 31, 2028
1 condition2 sponsors1 location
NCT05507008
Ketone Supplementation in Eating Disorders
NAActive, not recruiting
40 participants
Started: Oct 13, 2022 · Completed: Dec 30, 2026
4 conditions1 sponsor1 location
NCT05590715
International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder
N/ARecruiting
1,500 participants
Started: Oct 13, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor21 locations
NCT05596591
Focused Extracorporeal Shockwave Therapy for Knee Arthritis
NARecruiting
15 participants
Started: Oct 13, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors2 locations
NCT05341349
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases
PHASE1Active, not recruiting
1 participants
Started: Oct 13, 2022 · Completed: Mar 6, 2027
7 conditions3 sponsors1 location
NCT06167629
Monocentric Observational Study on the Diagnostic and Prognostic Role of 18F-PSMA PET (PET/CT and PET/MR) in Prostate Cancer
N/ARecruiting
2,500 participants
Started: Oct 13, 2022 · Completed: Jul 13, 2027
1 condition1 sponsor1 location
NCT05760235
Prospective Pilot Study for the Evaluation of Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Liver Transplant Candidates
NARecruiting
24 participants
Started: Oct 13, 2022 · Completed: Nov 30, 2024
3 conditions1 sponsor1 location
NCT05583201
NKG2D/CLDN18.2 CAR-T(KD-496) in the Treatment of Advanced NKG2DL+/CLDN18.2+ Solid Tumors
EARLY_PHASE1Recruiting
18 participants
Started: Oct 13, 2022 · Completed: Jun 1, 2026
3 conditions2 sponsors1 location